ENBI Surpasses "Triple Top" Key Breakout Point!

On Wednesday morning, NIA announced Entheon Biomedical (CSE: ENBI) at $1.02 per share as its #2 favorite psychedelic stock suggestion for 2021 and #1 favorite DMT stock suggestion for 2021. After gaining by 1.96% on Wednesday to $1.04 per share on huge volume of 1.491 million sharesENBI began to breakout big on Thursday and successfully surpassed its most important key breakout point!

Back on Friday, December 11th, ENBI closed at $0.89 per share and after word began to spread that weekend about ENBI being the only publicly traded DMT pure play in the psychedelic space, ENBI gapped up by 9% on Monday, December 14th to an opening price of $0.97 per share. From ENBI's December 14th open at $0.97 per share, ENBI proceeded to rally by an additional 18.56% to a high of day of $1.15 per share before closing at $1.03 per share on record volume of 3.739 million shares.

ENBI returned to $1.15 per share on both December 15th and December 16th but faced major resistance thereby forming a triple top, which is always the most difficult resistance for any stock to surpass! After forming a triple top at $1.15 per share, ENBI began a month long downtrend, which in reality was a best case scenario for the long-term health of ENBI's chart because the previous December 14th gap up got filled in and all profit takers and other weak hands had a chance to completely exit!

We can tell that many investors have been closely following ENBI from the sidelines because as soon as ENBI officially broke out of its downtrend two days ago, ENBI immediately rallied by 13.33% to a closing price on Tuesday of $1.02 per share on its highest volume in over a month! On Wednesday morning following NIA's initial announcement at $1.02 per share, ENBI once again traded huge volume of 1.491 million shares while gaining another 1.96% to $1.04 per share as short-term traders who bought on the dip were replaced by stronger hands who fully understand the potential of DMT and Ayahuasca from the dozens of videos produced by NIA's President Gerard Adams in recent years where he has interviewed many of the world's most successful entrepreneurs who have told their stories about how DMT and Ayahuasca have allowed them to greatly improve their mental well-being and achieve much greater success in all aspects of life!

Today, ENBI successfully surpassed its most important key breakout point of $1.15 per share where it previously tripled topped in mid-December! ENBI gained by $0.21 or 20.19% today to close at its high of day and new all-time high of $1.25 per share on enormous volume of 1.903 million shares (its second highest volume day in history)! ENBI reminds us of NUMI before its rally in December!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from ENBI of USD$30,000 cash for a three-month marketing contract. NIA has received compensation from NUMI of USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.